Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14157332 | 0.79 | GABRA1 (0.35) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL7037210 | 0.77 | GABRA1 (0.33) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL9244695 | 0.76 | GABRA1 (0.48) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL4632329 | 0.76 | GABRA1 (0.38) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL27506728 | 0.76 | EIF4A3 (0.30) | — | |
| SCHEMBL9245578 | 0.76 | GABRA1 (0.31) | GABRA1GABRB1 | |
| SCHEMBL2138025 | 0.76 | — | — | |
| SCHEMBL3236614 | 0.76 | GABRA1 (0.31) | GABRA1GABRB1 | |
| SCHEMBL9672407 | 0.76 | AHR (0.32) | GABRA1GABRB2 | |
| SCHEMBL2138031 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 546 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118255642-A | Asymmetric synthesis method and application of chiral primary amine compound | 中国科学院深圳先进技术研究院 | 2024-06-28 | — | — | CN | claimed |
| WO-2024124895-A1 | SYNTHESIS METHOD FOR CHIRAL PHOSPHORIC ACID CATALYST | 上海泰坦科技股份有限公司 | 2024-06-20 | — | — | WO | claimed |
| CN-118184915-A | Propylene and alpha-olefin multi-block copolymer elastomer material, and preparation method and application thereof | 天津大学 | 2024-06-14 | — | — | CN | claimed |
| EP-4370500-A1 | AROMATIC CARBODIIMIDES, PROCESS FOR THE PREPARATION AND USE THEREOF | LANXESS Deutschland GmbH (DE) | 2024-05-22 | — | — | EP | claimed |
| WO-2024098464-A1 | PREPARATION METHOD FOR OPTICALLY PURE α-ARYL CHIRAL AMINE COMPOUND, AND USE THEREOF | 深圳先进技术研究院 | 2024-05-16 | — | — | WO | claimed |
| CN-118026793-A | Preparation method and application of optically pure alpha-aryl chiral amine compound | 深圳先进技术研究院 | 2024-05-14 | — | — | CN | claimed |
| CN-117831652-A | Prediction method of olefin hydroformylation positive-to-negative ratio | 上海华谊控股集团有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117616009-A | Aromatic carbodiimide, method for producing same and use thereof | 朗盛德国有限责任公司 | 2024-02-27 | — | — | CN | claimed |
| EP-4244202-A1 | METHOD OF SYNTHESIS | University of Durham (GB) | 2023-09-20 | — | — | EP | claimed |
| US-20230292591-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-14 | — | — | US | claimed |
| US-20030083517-A1 | Methods of preparing sulfinamides and sulfoxides | APSINTERM LLC | 2003-05-01 | — | — | US | claimed |
| EP-1098651-B1 | NOVEL UROKINASE INHIBITORS | WILEX AG (DE) | 2003-01-08 | — | — | EP | claimed |
| WO-2002083608-A2 | METHODS OF PREPARING SULFINAMIDE AND SULFOXIDES | APSINTERM LLC (US) | 2002-10-24 | — | — | WO | claimed |
| EP-1021449-B1 | HYDROXYACETIC ESTER DERIVATIVES, PREPARATION METHOD AND USE AS SYNTHESIS INTERMEDIATES | SANOFI SYNTHELABO (FR) | 2002-01-02 | — | — | EP | claimed |
| EP-0649877-B1 | Self-lubricating mixtures | GE BAYER SILICONES GMBH & CO (DE) | 2001-03-28 | — | — | EP | claimed |
| EP-1021449-A1 | HYDROXYACETIC ESTER DERIVATIVES, PREPARATION METHOD AND USE AS SYNTHESIS INTERMEDIATES | SANOFI-SYNTHELABO (FR) | 2000-07-26 | — | — | EP | claimed |
| WO-1999018110-A1 | HYDROXYACETIC ESTER DERIVATIVES, PREPARATION METHOD AND USE AS SYNTHESIS INTERMEDIATES | SANOFI-SYNTHELABO (FR) | 1999-04-15 | — | — | WO | claimed |
| EP-0071150-B1 | SULFIMINES, THEIR SALTS AND THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1985-07-03 | — | — | EP | claimed |
| US-4507479-A | Color-forming sulfonamidodiphenylamine dye precursor that produces phenazine dye | EASTMAN KODAK COMPANY (US) | 1985-03-26 | — | — | US | claimed |
| US-3936410-A | Triaryl phosphate ester plasticizers for polyvinyl chloride compositions | FMC CORPORATION (US) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292591-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | POF1B, FOSB, OSBP | FAAH 1526/4885CA1 2547/4885CA2 2862/4885 |
| US-20030083517-A1 | Methods of preparing sulfinamides and sulfoxides | STS, TST, CBS | FAAH 2049/4885CA1 1528/4885CA2 3428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.